Erythromycin Lactobionate Injection Shortage
Last Updated: May 30, 2025
Status: Current
Products Affected - Description
-
- Erythrocin powder for solution for injection, Pfizer, 500 mg, vial, 10 count, NDC 00409-6482-01
- Erythromycin Lactobionate powder for solution for injection, Nexus Pharmaceuticals, 500 mg, vial, 10 count, NDC 14789-0116-05
Reason for the Shortage
-
- Nexus has 500 mg vials on shortage due to increased demand.
- Pfizer has Erythrocin on shortage due to manufacturing delays.
Available Products
-
- Erythrocin powder for solution for injection, Pfizer, 500 mg, ADD-Vantage vial, 10 count, NDC 00409-6476-44
Estimated Resupply Dates
-
- Pfizer has short-dated Erythrocin 500 mg vials available in limited supply with an expiration date of July 2025. The company estimates a release date of September 2025 for vials with regular dating.
- Nexus has erythromycin 500 mg vials on back order and the company estimates a release date of late-3rd quarter or early-4th quarter 2025.
Updated
Updated May 30, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. Created April 21, 2025 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2025, Drug Information Service, University of Utah, Salt Lake City, UT.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.